SignatureFD’s Medifast MED Stock Holding History

SignatureFD’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.39K	Sell	697 -223	-24%	-$2.57K	﹤0.01%	2751
2026 Q1	$9.38K	Hold	920	–	–	﹤0.01%	2547
2025 Q4	$9.83K	Buy	920 +218	+31%	+$2.61K	﹤0.01%	2442
2025 Q3	$9.6K	Hold	702	–	–	﹤0.01%	2418
2025 Q2	$9.86K	Hold	702	–	–	﹤0.01%	2356
2025 Q1	$9.46K	Hold	702	–	–	﹤0.01%	2382
2024 Q4	$12.4K	Hold	702	–	–	﹤0.01%	2293
2024 Q3	$13.4K	Sell	702 -163	-19%	-$3.14K	﹤0.01%	2223
2024 Q2	$18.9K	Buy	865 +98	+13%	+$2.61K	﹤0.01%	1999
2024 Q1	$29.4K	Buy	767 +25	+3%	+$1.21K	﹤0.01%	1807
2023 Q4	$49.9K	Sell	742 -72	-9%	-$5.02K	﹤0.01%	1464
2023 Q3	$60.9K	Sell	814 -112	-12%	-$9.94K	﹤0.01%	1302
2023 Q2	$85.3K	Buy	926 +889	+2,403%	+$79.1K	﹤0.01%	1144
2023 Q1	$3.84K	Sell	37 -26	-41%	-$2.88K	﹤0.01%	2606
2022 Q4	$7.27K	Sell	63 -20	-24%	-$2.33K	﹤0.01%	2283
2022 Q3	$9K	Buy	83 +21	+34%	+$3.01K	﹤0.01%	2132
2022 Q2	$11K	Buy	62 +45	+265%	+$8.05K	﹤0.01%	2072
2022 Q1	$3K	Buy	17 +12	+240%	+$2.26K	﹤0.01%	2697
2021 Q4	$1K	Hold	5	–	–	﹤0.01%	2950
2021 Q3	$1K	Buy	+5	New	+$1.23K	﹤0.01%	2860
2019 Q4	–	Sell	-13	Closed	-$1K	–	2231
2019 Q3	$1K	Buy	+13	New	+$1.4K	﹤0.01%	1972

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SignatureFD's MED Position: Q2 2026 in Review

SignatureFD reduced its Medifast (MED) stake by 24% in Q2 2026, selling an estimated $2.57K and leaving 697 shares worth $7.39K. The position accounts for ﹤0.01% of the portfolio, ranked #2751.

SignatureFD first reported a position in MED in Q3 2019 and has held it in 21 quarters since. The position peaked at $85.3K in Q2 2023. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

SignatureFD held 697 shares of Medifast worth $7.39K as of Q2 2026.
SignatureFD sold 223 Medifast shares in Q2 2026, an estimated $2.57K.
Medifast made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2751 holding.
SignatureFD first reported a position in Medifast in Q3 2019 and has held it in 21 quarters since.
SignatureFD's Medifast position peaked at $85.3K in Q2 2023.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.